SAMANTHA NEAL: Open Payments
NPI 1578173076 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 39 payments from 15 companies in 2025. Trend: 2023 $397 · 2024 $407 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $228 |
| Organon LLC | 5 | $108 |
| PFIZER INC. | 4 | $104 |
| CooperSurgical, Inc. | 4 | $72 |
| SHIELD THERAPEUTICS INC | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| MILLICENT US INC | 3 | $61 |
| Sage Therapeutics, LLC | 3 | $48 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $28 |
Products named: MYFEMBREE, NEXPLANON, ABRYSVO, ACCRUFER, ZURZUVAE, INTRAROSA, Mirena, Qelbree.
Industry payments across TX — which companies pay providers there.
